Provides research and learning information, software and services to universities, research institutions and governments.
10-K for FY2025, filed Feb 24, 2026
Customers pay subscription fees at the start of each coverage period for product access or maintenance; patent and trademark renewal services and specific product, data-set or project deliverables are invoiced upon delivery.
10-K for FY2025, filed Feb 24, 2026Subscription-based revenues are recurring revenues that we typically earn under annual contracts, pursuant to whichView ↗
We invoice and collect the subscription fee at the beginning of the subscription period. For multi-year agreements, we generally invoice…View ↗
Re-occurring revenues are derived solely from the patent and trademark renewal services provided by our IPView ↗
Transactional revenues are earned for specific deliverables that are typically quoted on a product, data set, or projectView ↗
basis. Transactional revenues include content sales (including single-document and aggregated collection sales), consulting engagements…View ↗
10-K for FY2025, filed Feb 24, 2026
FY2025 revenue by reportable segment ↗$2.5B
10-K for FY2025, filed Feb 24, 2026
$2.5B ↗| Segment | Share | Revenue |
|---|---|---|
|
A&G
|
52%
FY2022: 48%
|
A&G, FY2025
$1.3B Sources
|
|
IP
|
33%
FY2022: 35%
|
IP, FY2025
$799.4M Sources
|
|
Life Sciences & Healthcare
|
16%
FY2022: 17%
|
Life Sciences & Healthcare, FY2025
$389.8M Sources
|
Serves academic and research institutions and libraries, government entities, and businesses including corporations, law firms, and pharmaceutical, biotechnology and medical-device companies.
10-K for FY2025, filed Feb 24, 2026We serve more than 45,000 customers worldwide, including academic institutions and libraries, research organizations, corporations, law…View ↗
Not on paper. It lost $201.1M in FY2025, but brought in more cash than it spent: $365.3M of free cash flow.
10-Q for Q3 FY2026, filed Nov 3, 2026
−$80.8MView ↗
10-Q for Q3 FY2026, filed Nov 3, 2026
Open tableView ↗
8-K, filed Nov 3, 2026
Revenues $1.965B to $1.985B $490M to $510MView ↗
8-K, filed Oct 6, 2026
At the closing of the Transaction (the “Closing”), Buyer paid to a wholly-owned subsidiary of Clarivate cash consideration of $500,000,000…View ↗
Growing. Revenue grew 31% in 4 years, from $1.9B in FY2021 to $2.5B in FY2025, about 7% a year.
A&G product portfolio
The older report listed ScholarOne among A&G products; the latest says Clarivate divested ScholarOne and Valipat and began winding down product groups in A&G and Life Sciences & Healthcare.
10-K for FY2022, filed Mar 1, 2023 10-K for FY2025, filed Feb 24, 2026Our A&G segment supports academic institutions on their quest to build a better world by connecting students, faculty and staff to…View ↗
Streamline business model and market focus. Complete product group wind-downs started in 2025 within theView ↗
Loading...